Comprehensive analyses reveal treatment efficacy in bladder cancer, suggesting optimized individual therapy decisions.
Our signature further illustrated heterogeneity of BLCA. This signature could predict prognosis, consensus subtypes and treatment efficacy. We believe that this signature can optimize individual treatment decisions.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: